SCHEMBL2326281

SCHEMBL2326281

CCCO[Sn](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 3/20 0.36
LTA4H P09960 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TP53 P04637 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA7 P36544 1/20 0.31
CHRNA4 P43681 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
KCNA3 P22001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2325012 0.87 LTA4H (0.47) HPGDALDH1A1LTA4HCYP1A2CYP2C9
SCHEMBL2326443 0.85 LTA4H (0.47) LMNAALDH1A1LTA4HCYP1A2CYP2C9
SCHEMBL2327150 0.84 LTA4H (0.46) MEN1KMT2ALMNAALDH1A1LTA4H
SCHEMBL2326448 0.84 LTA4H (0.46) MEN1KMT2ALMNAALDH1A1LTA4H
SCHEMBL2324744 0.84 LTA4H (0.46) MEN1KMT2ALMNAALDH1A1LTA4H
SCHEMBL2328036 0.84 LTA4H (0.46) MEN1KMT2ALMNAALDH1A1LTA4H
SCHEMBL2328127 0.84 LTA4H (0.46) MEN1KMT2ALMNAALDH1A1LTA4H
SCHEMBL2329511 0.82 MEN1 (0.44) HPGDMEN1KMT2ALMNAALDH1A1
SCHEMBL2328167 0.81 ALDH1A1 (0.37) MEN1KMT2AALDH1A1LTA4HCYP2C19
SCHEMBL2347611 0.78 MEN1 (0.41) HPGDMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987881-B1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE ASAHI KASEI CHEMICALS CORP (JP) 2011-08-17 EP disclosed
US-7842828-B2 Method for separating out and recovering dialkyltin dialkoxide ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-11-30 US disclosed
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-06-24 US disclosed
EP-1987881-A1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE Asahi Kasei Chemicals Corporation (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ALOX5, ALOX15B, ALOX15 HPGD 376/4885MEN1 3047/4885KMT2A 1615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.